Of note, JNK1/2LPC-KO and JNK1/2Δhep mice in our study showed no evidence of hepatocellular carcinoma or cholangiocarcinoma up to the age of 52 wk. This evidence concerns the gene MAPK8 and cholangiocarcinoma.